PDK4 and lung cancer: (76) integrated clinical phenomics, lipidomics, and transcriptomics and found that PA can modulate the expression of the pyruvate dehydrogenase kinase 4 (PDK4) gene and ACSL5 gene in different patterns, leading to the inhibition of proliferation in lung adenocarcinoma or small lung cancer cells by altering cellular energy metabolism.